On December 11, recombinant carboxypeptidase G2 for injection, a new class 1 biological product developed by our company, took part in the 89th item roadshow of Guangdong Yigu Open Day. As the only biopharmaceutical in this roadshow, Guangdong Yigu has attached great importance to it. Chief Executive Officer Xie has had an in-depth exchange with us, introduced the situation of Guangdong Yigu industrial incubator, and learned about the situation of our company in detail, the two sides reached an intention of further cooperation.

  During the roadshow, the company's Teacher Xin Yu gave a wonderful project speech and accepted the judges'questions on the spot. The industry colleagues and investors attending the meeting asked me carefully about the company's product pipeline, the project's R & D process and the development results, the recombinant carboxypeptidase G2 for injection, which is urgently needed in clinic and has a broad market prospect, is highly evaluated, and has a strong interest in our follow-up projects.

  After the roadshow, teacher Xin Yu gave an on-the-spot interview on Medical Chinese net, and made a multi-angle introduction on the development history, future prospect, project planning and Industry Situation of our company, and achieved good results.